Global Sevoflurane Sales Market Report 2023

Sevoflurane Source (Sevoflurane) is a halogenated general inhalation anesthetic drug. It’s a volatile liquid for inhalation, a nonflammable and nonexplosive liquid administered by vaporization.

In this report, one unit is 250 ml Sevoflurane.

Market Analysis and Insights: Global Sevoflurane Market

Due to the COVID-19 pandemic, the global Sevoflurane market size is estimated to be worth US$ 1322.6 million in 2022 and is forecast to a readjusted size of US$ 1276.4 million by 2029 with a CAGR of -0.5% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Generic Drug accounting for % of the Sevoflurane global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Hospitals segment is altered to an % CAGR throughout this forecast period.

Europe is the largest Sevoflurane market with about 40% market share. Asia is follower, accounting for about 25% market share.

The key players are Abbott, Baxter, Maruishi, Jiangsu Hengrui, Lunan etc. Top 3 companies occupied about 63% market share.

Global Sevoflurane Scope and Market Size

The global Sevoflurane market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Sevoflurane market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.


Segment by Type


Generic Drug

Original Drug


Segment by Application


Hospitals

Other Medical Institutions

By Region

United States

Europe

China

Japan

Southeast Asia

India

Other Regions


By Company


Abbott

Baxter

Maruishi

Jiangsu Hengrui

Lunan